Literature DB >> 21550576

Older blood pressure medications-do they still have a place?

Hanna B Slim1, Henry R Black, Paul D Thompson.   

Abstract

Hypertension is a major risk factor for cardiovascular disease, but control of hypertension remains inadequate, often because of poor patient adherence to prescribed medical regimens that are viewed as poorly tolerated and expensive. Physicians have largely stopped using some older blood pressure medications in favor of newer agents, mostly because of a presumed more favorable side effect profile. The investigators reviewed the pharmacologic properties and the evidence supporting the effectiveness and tolerability of several older blood pressure drugs: sympatholytic agents such as reserpine, methyldopa, and clonidine; diuretics such as chlorthalidone, ethacrynic acid and spironolactone; the vasodilators hydralazine and minoxidil; and others. In conclusion, some of these drugs are well studied and represent alternatives for patients who cannot afford or tolerate newer medications.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550576     DOI: 10.1016/j.amjcard.2011.03.041

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list.

Authors:  Ute Amann; Niklas Schmedt; Edeltraut Garbe
Journal:  Dtsch Arztebl Int       Date:  2012-02-03       Impact factor: 5.594

Review 2.  Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

Authors:  Hamish Cg Prosser; Cynthia Gregory; Dagmara Hering; Graham S Hillis; Greg Perry; Johan Rosman; Carl Schultz; Mark Thomas; Gerald F Watts; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

3.  What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated?

Authors:  Domenic A Sica
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

4.  Covalent adduct formation between the antihypertensive drug hydralazine and abasic sites in double- and single-stranded DNA.

Authors:  Douglas Melton; Calvin D Lewis; Nathan E Price; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2014-11-18       Impact factor: 3.739

5.  No association between low-dose reserpine use and depression in older hypertensive patient: result of a multicenter, cross-sectional study.

Authors:  Guo-Hua Zhu; Xi-Peng Sun; Jing Li; Lin Pi; Hai-Qin Tang; Hai-Qing Gao; Hong-Liang Cong; Peng Qu; Xin-Zheng Lu; Xin-Jun Zhang; Luo-Sha Zhao; Yi-Fang Guo; Dong-Xia Liu; Liang-Qing Zhang; Hua Tang; Yi-Xin Hu; Li Fan; Qi Hua
Journal:  J Geriatr Cardiol       Date:  2019-08       Impact factor: 3.327

6.  Bioactivity-Guided Isolation and Identification of New and Immunosuppressive Monoterpenoid Indole Alkaloids from Rauvolfia yunnanensis Tsiang.

Authors:  Li-Mei Li; Shun-Dong Shi; Yang Liu; Qiang Zou
Journal:  Molecules       Date:  2019-12-13       Impact factor: 4.411

7.  Risks associated with continuation of potentially inappropriate antihypertensive medications in older adults receiving hemodialysis.

Authors:  Rasheeda K Hall; Sarah Morton; Jonathan Wilson; Patti L Ephraim; L Ebony Boulware; Wendy L St Peter; Cathleen Colón-Emeric; Jane Pendergast; Julia J Scialla
Journal:  BMC Nephrol       Date:  2021-06-19       Impact factor: 2.585

8.  Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart.

Authors:  Eva Gabrielová; Aleksey Vladimirovich Zholobenko; Lenka Bartošíková; Jiří Nečas; Martin Modriansky
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.